tiprankstipranks
Context Therapeutics (CNTX)
NASDAQ:CNTX
Holding CNTX?
Track your performance easily

Context Therapeutics (CNTX) Ownership - Who Owns Context Therapeutics?

89 Followers

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$2666936
Sep 30, 2024
xxxxxxxxxxxxx
$4783046

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,400,378Institution5.87%6,600,567
3,196,224Institution4.26%4,794,336
2,440,330Institution3.25%3,660,495
2,258,065Institution3.01%3,387,098
1,360,682Institution1.81%2,041,023
979,891Insider1.31%1,469,837
645,231Institution0.86%967,847
61,983Insider0.08%92,975
53,125Institution0.07%79,688
41,469Institution0.06%62,204

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,400,378Institution5.87%6,600,567
645,231Institution0.86%967,847
53,125Institution0.07%79,688
41,469Institution0.06%62,204
1,801Institution<0.01%2,702

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,641,400Institution3.52%5,758,252
554,824Institution0.74%1,209,516

FAQ

Who Owns Context Therapeutics (CNTX)?
Currently, no data Available
What percentage of Context Therapeutics (CNTX) stock is held by institutional investors?
Currently, no data Available
What percentage of Context Therapeutics (CNTX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Context Therapeutics (CNTX)?
VANGUARD INDEX FUNDS owns the most shares of Context Therapeutics (CNTX).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis